Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation

SIMPLE SUMMARY: Upfront genetics/cytogenetics and minimal measurable disease (MRD) are becoming relevant biomarkers in the process of post-remission transplant allocation in AML. However, until recently the transplantation choice relied on the availability of a fully matched familiar donor, whereas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Buccisano, Francesco, Palmieri, Raffaele, Piciocchi, Alfonso, Maurillo, Luca, Del Principe, Maria Ilaria, Paterno, Giovangiacinto, Soddu, Stefano, Cerretti, Raffaella, De Angelis, Gottardo, Mariotti, Benedetta, Irno Consalvo, Maria Antonietta, Conti, Consuelo, Fraboni, Daniela, Divona, Mariadomenica, Ottone, Tiziana, Lavorgna, Serena, Panetta, Paola, Voso, Maria Teresa, Arcese, William, Venditti, Adriano
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959451/
https://ncbi.nlm.nih.gov/pubmed/33802502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados